| # | Drug | Count |
|---|---|---|
| 0 | CLOPIDOGREL | 20 |
| 1 | CLOPIDOGREL BISULFATE | 18 |
| 2 | METFORMIN | 16 |
| 3 | METFORMIN ER 500 MG | 15 |
| 4 | METFORMIN ER 750 MG | 15 |
| 5 | NEBIVOLOL | 15 |
| 6 | NEBIVOLOL HYDROCHLORIDE | 15 |
| 7 | SIMVASTATIN | 15 |
| 8 | ASPIRIN | 13 |
| 9 | ASPIRIN 325 MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAXOLOL HYDROCHLORIDE | 3 | 0.0058 |
| 1 | SILODOSIN | 10 | 0.0024 |
| 2 | EPINEPHRINE HYDROCHLORIDE | 1 | 0.0021 |
| 3 | SOLIFENACIN SUCCIATE | 3 | 0.0016 |
| 4 | EPTIFIBATIDE | 1 | 0.0013 |
| 5 | STREPTOMYCIN | 1 | 0.0009 |
| 6 | CHLOROTHIAZIDE | 1 | 0.0008 |
| 7 | NATEGLINIDE | 1 | 0.0007 |
| 8 | TRIMETHOBENZAMIDE HYDROCHLORIDE | 1 | 0.0007 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 24 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 22 |
| 2 | beta-Adrenergic Blocker [EPC] | 20 |
| 3 | P2Y12 Platelet Inhibitor [EPC] | 18 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 17 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 7 | Benzodiazepine [EPC] | 13 |
| 8 | alpha-Adrenergic Blocker [EPC] | 13 |
| 9 | Factor Xa Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Amyloid Beta-directed Antibody [EPC] | 2 | 0.0005 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 2 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 3 | 0.0002 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 18 | 0.0002 |
| 6 | Glinide [EPC] | 1 | 0.0001 |
| 7 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |